Credit Suisse Ag Macrogenics Inc Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Macrogenics Inc stock. As of the latest transaction made, Credit Suisse Ag holds 35,864 shares of MGNX stock, worth $116,916. This represents 0.0% of its overall portfolio holdings.

Number of Shares

35,864

Holding current value

$116,916

% of portfolio

0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$9.77 - $21.47 $350,391 - $770,000	35,864 New	35,864 $527,000
Q4 2022 Feb 13, 2023	SELL	$3.34 - $6.98 $184,237 - $385,023	-55,161 Reduced 100.0%	2 $0
Q3 2022 Nov 10, 2022	BUY	$3.01 - $5.22 $1,059 - $1,837	352 Added 0.64%	55,163 $190,000
Q2 2022 Aug 12, 2022	BUY	$2.25 - $9.99 $1,777 - $7,892	790 Added 1.46%	54,811 $161,000
Q1 2022 May 16, 2022	BUY	$8.12 - $16.9 $41,809 - $87,018	5,149 Added 10.54%	54,021 $475,000
Q4 2021 Feb 14, 2022	SELL	$15.91 - $21.88 $46,266 - $63,627	-2,908 Reduced 5.62%	48,872 $784,000
Q3 2021 Nov 12, 2021	BUY	$19.74 - $28.7 $50,040 - $72,754	2,535 Added 5.15%	51,780 $1.08 Million
Q2 2021 Aug 16, 2021	BUY	$20.49 - $35.63 $60,711 - $105,571	2,963 Added 6.4%	49,245 $1.32 Million
Q1 2021 May 14, 2021	SELL	$18.99 - $33.2 $923,977 - $1.62 Million	-48,656 Reduced 51.25%	46,282 $1.47 Million
Q4 2020 Feb 12, 2021	BUY	$19.41 - $26.0 $182,143 - $243,984	9,384 Added 10.97%	94,938 $2.17 Million
Q3 2020 Nov 13, 2020	BUY	$24.69 - $31.6 $619,867 - $793,349	25,106 Added 41.53%	85,554 $2.16 Million
Q2 2020 Aug 12, 2020	BUY	$5.2 - $29.12 $116,017 - $649,696	22,311 Added 58.5%	60,448 $1.69 Million
Q1 2020 May 13, 2020	SELL	$4.28 - $12.11 $23,231 - $65,733	-5,428 Reduced 12.46%	38,137 $222,000
Q4 2019 Feb 12, 2020	BUY	$7.95 - $12.27 $90,852 - $140,221	11,428 Added 35.56%	43,565 $474,000
Q3 2019 Nov 12, 2019	BUY	$12.44 - $17.48 $73,097 - $102,712	5,876 Added 22.38%	32,137 $410,000
Q2 2019 Aug 14, 2019	SELL	$14.51 - $19.71 $48,710 - $66,166	-3,357 Reduced 11.33%	26,261 $445,000
Q1 2019 May 14, 2019	BUY	$11.11 - $25.6 $43,884 - $101,120	3,950 Added 15.39%	29,618 $531,000
Q4 2018 Feb 13, 2019	BUY	$11.75 - $21.42 $12,807 - $23,347	1,090 Added 4.43%	25,668 $326,000
Q3 2018 Nov 13, 2018	SELL	$19.26 - $23.46 $179,272 - $218,365	-9,308 Reduced 27.47%	24,578 $527,000
Q2 2018 Aug 14, 2018	SELL	$19.78 - $24.67 $86,636 - $108,054	-4,380 Reduced 11.45%	33,886 $699,000
Q1 2018 May 15, 2018	BUY	$18.89 - $32.46 $47,678 - $81,929	2,524 Added 7.06%	38,266 $964,000
Q4 2017 Feb 14, 2018	SELL	$16.19 - $20.3 $164,700 - $206,511	-10,173 Reduced 22.16%	35,742 $678,000
Q3 2017 Nov 14, 2017	BUY	$15.52 - $18.94 $293,203 - $357,814	18,892 Added 69.91%	45,915 $849,000
Q2 2017 Aug 14, 2017	BUY	N/A	27,023	27,023 $473,000

Others Institutions Holding MGNX

# of Institutions

132

Shares Held

55.4M

Call Options Held

215K

Put Options Held

238K

Bellevue Group Ag Kuesnacht, V8

9.93M
Shares

$32.4 Million
0.55% of portfolio
Armistice Capital, LLC New York, NY

6.26M
Shares

$20.4 Million
0.34% of portfolio
Black Rock Inc. New York, NY

5.4M
Shares

$17.6 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

4.36M
Shares

$14.2 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

3.54M
Shares

$11.5 Million
0.01% of portfolio

View Full List

About MACROGENICS INC

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $200M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

More about MGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account